Mineralys Therapeutics, Inc. (MLYS)
29.77
+1.56
(+5.53%)
USD |
NASDAQ |
Feb 06, 16:00
30.31
+0.54
(+1.81%)
After-Hours: 20:00
Mineralys Therapeutics EPS Diluted (Quarterly) : -0.5232 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Insmed, Inc. | -1.747 |
| Nektar Therapeutics | -1.875 |
| Lyell Immunopharma, Inc. | -2.126 |
| Arrowhead Pharmaceuticals, Inc. | 0.219 |
| Cidara Therapeutics, Inc. | -3.096 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -36.93M |
| Total Expenses (Quarterly) | 36.93M |
| Enterprise Value | 1.762B |
| Earnings Yield | -9.94% |
| Normalized Earnings Yield | -9.936 |